Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abcertin (ISU302) in Type 1 Gaucher Disease
NCT02770625Phase 3Completed
- Sponsor
- ISU Abxis Co., Ltd.
- Start
- Sep 2011
- Primary completion
- Mar 2013
- Modality
- Replacement Enzymes
01
Overview
A Phase 3 trial of imiglucerase in Gaucher disease type 1 (GD1), sponsored by ISU Abxis Co., Ltd.. Started Sep 2011; status: completed.
02
Drugs
imiglucerase
03
Conditions
Gaucher disease type 1 (GD1)
Beyond the preview
Go deeper on NCT02770625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02770625.